III FERO – GHD Project – Dr. Verónica Rodilla

Her project focuses on applying personalized medicine to the research of two very specific types of breast cancer: the so-called ‘triple-negative’ due to its high aggressiveness, and ‘luminal breast cancer,’ which has lower aggressiveness but is one of the most common in Spain. The aim is to identify reliable biomarkers for three types of mammary epithelial cells, allowing for more precise tumor subclassification and defining which cells respond better to current treatments and which are more prone to generating metastases. Based on this, more patients with these cancer subtypes can be considered ‘eligible’ for targeted therapies.